Cerezyme
Active Ingredient(s): ImigluceraseFDA Approved: * May 23, 1994
Pharm Company: * GENZYME
Category: Enzymes
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Cerezyme Overview
Imiglucerase is a medication used in the treatment of Gaucher's disease.[1][2] It is a recombinant DNA-produced analogue of the human enzyme β-glucocerebrosidase. Cerezyme is a freeze-dried medicine containing imiglucerase, manufactured by Genzyme Corporation. It is given intravenously after reconstitution as a treatment for Type 1 and Type 3[3] Gaucher's disease. It is available in formulations containing 200 or 400 units per vial. The sp...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Imiglucerase
Recent Cerezyme Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Imiglucerase
- Injection: 200 units/vial, 200unit, 400 units/vial, 400unit
NDC Database Records for Cerezyme: (2 results)
Sorted by National Drug Code- 58468-1983 Cerezyme 40 U/Ml Intravenous Injection, Powder, Lyophilized, for Solution by Genzyme Corporation
- 58468-4663 Cerezyme 40 U/Ml Intravenous Injection, Powder, Lyophilized, for Solution by Genzyme Corporation